-
EP3894557
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3894557
| EP3894557 - COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 19.05.2023 Database last updated on 08.04.2026 | |
| Former | Request for examination was made Status updated on 17.09.2021 | ||
| Former | The international publication has been made Status updated on 20.06.2020 | ||
| Former | unknown Status updated on 23.01.2020 | Most recent event Tooltip | 18.12.2025 | New entry: Renewal fee paid | Applicant(s) | For all designated states Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 / US | [2024/44] |
| Former [2021/42] | For all designated states Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 / US | ||
| For all designated states Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 / US | Inventor(s) | 01 /
NESTOROV, Ivan Alexandrov Biogen MA Inc. 225 Binney Street Cambridge, Massachusetts 02142 / US | 02 /
FERGUSON, Toby Biogen MA Inc. 225 Binney Street Cambridge, Massachusetts 02142 / US | 03 /
NORRIS, Daniel A. Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, California 92010 / US | [2021/42] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2021/42] | Application number, filing date | 19836331.9 | 12.12.2019 | [2021/42] | WO2019US65936 | Priority number, date | US201862779916P | 14.12.2018 Original published format: US 201862779916 P | US201962807603P | 19.02.2019 Original published format: US 201962807603 P | US201962840879P | 30.04.2019 Original published format: US 201962840879 P | [2021/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020123783 | Date: | 18.06.2020 | Language: | EN | [2020/25] | Type: | A1 Application with search report | No.: | EP3894557 | Date: | 20.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.06.2020 takes the place of the publication of the European patent application. | [2021/42] | Search report(s) | International search report - published on: | EP | 18.06.2020 | Classification | IPC: | C12N15/113, A61P25/14 | [2021/42] | CPC: |
C12N15/1137 (EP,CN,IL,KR,US);
A61K31/7088 (CN);
A61K31/7105 (KR);
A61P21/00 (CN);
A61P25/00 (CN);
A61P25/28 (KR);
C12N9/0089 (KR);
C12Y115/01001 (KR,US);
C12N2310/11 (EP,CN,IL,KR,US);
C12N2310/315 (EP,IL,US);
C12N2310/321 (IL,KR,US);
C12N2310/322 (KR);
C12N2310/3341 (EP,IL,KR,US);
C12N2310/3525 (IL,KR,US);
C12N2320/32 (CN);
C12N2320/35 (EP,IL,KR,US)
(-)
| C-Set: |
C12N2310/321, C12N2310/3525 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/42] | Extension states | BA | 06.07.2021 | ME | 06.07.2021 | Validation states | KH | 06.07.2021 | MA | 06.07.2021 | MD | 06.07.2021 | TN | 06.07.2021 | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND VORBEUGUNG VON AMYOTROPHER LATERALSKLEROSE | [2021/42] | English: | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS | [2021/42] | French: | COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT ET LA PRÉVENTION DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE (SLA) | [2021/42] | Entry into regional phase | 06.07.2021 | National basic fee paid | 06.07.2021 | Designation fee(s) paid | 06.07.2021 | Examination fee paid | Examination procedure | 06.07.2021 | Amendment by applicant (claims and/or description) | 06.07.2021 | Examination requested [2021/42] | 06.07.2021 | Date on which the examining division has become responsible | 23.05.2023 | Despatch of a communication from the examining division (Time limit: M06) | 27.11.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 30.11.2021 | Renewal fee patent year 03 | 20.12.2022 | Renewal fee patent year 04 | 19.12.2023 | Renewal fee patent year 05 | 19.12.2024 | Renewal fee patent year 06 | 17.12.2025 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I] WO2015153800 (ISIS PHARMACEUTICALS INC et al.) | [A] WO2018204786 (VOYAGER THERAPEUTICS INC et al.) | [I] ALEX MCCAMPBELL ET AL: "Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models", JOURNAL OF CLINICAL INVESTIGATION, vol. 128, no. 8, 16 July 2018 (2018-07-16), GB, pages 3558 - 3567, XP055679194, ISSN: 0021-9738, DOI: 10.1172/JCI99081 DOI: http://dx.doi.org/10.1172/JCI99081 | [A] SCHOCH KATHLEEN M ET AL: "Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases", NEURON, vol. 94, no. 6, 21 June 2017 (2017-06-21), pages 1056 - 1070, XP085093439, ISSN: 0896-6273, DOI: 10.1016/J.NEURON.2017.04.010 DOI: http://dx.doi.org/10.1016/j.neuron.2017.04.010 | by applicant | WO03004602 | FRIDOVICH, ANNU. REV. BIOCHEM., vol. 64, 1995, pages 97 - 112 | TURRENS, J. PHYSIOL., vol. 552, 2003, pages 335 - 344 | ROWLAND, N. ENGL. J. MED., vol. 344, 2001, pages 1688 - 1700 | ROSEN, NATURE, vol. 364, no. 6435, 1993, pages 362 - 62 | SAU, HUM. MOL. GENET., vol. 16, 2007, pages 1604 - 1618 | BRUIJN ET AL., SCIENCE, vol. 281, no. 5384, 1998, pages 1851 - 4 | CONWIT RA, JNEUROL SCI., vol. 251, no. 1-2, 2006, pages 1 - 2 | AL-CHALABI ALEIGH PN, CURR.OPIN. IN NEUROL., vol. 13, no. 4, 2000, pages 397 - 405 | REDLER RLDOKHOLYAN NV, PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE, vol. 107, 2012, pages 215 - 62 | JONES, L.J. ET AL., ANALYTICAL BIOCHEMISTRY, vol. 265, 1998, pages 368 - 374 |